Dr Lionel Julian Handler, MD | |
10105 Banburry Cross Dr, Suite 350, Las Vegas, NV 89144 | |
(702) 243-6400 | |
(702) 243-4913 |
Full Name | Dr Lionel Julian Handler |
---|---|
Gender | Male |
Speciality | Micrographic Dermatologic Surgery (mds) |
Experience | 32 Years |
Location | 10105 Banburry Cross Dr, Las Vegas, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013988260 | NPI | - | NPPES |
002019937 | Medicaid | NV | |
990010823 | Other | NV | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ND0101X | Dermatology - Mohs-micrographic Surgery | MD8425 (Nevada) | Secondary |
207N00000X | Dermatology | MD8425 (Nevada) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Robert B Strimling Md And Associates Llc | 6901934561 | 2 |
News Archive
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Leading micro-engineering company Epigem today announced a new Knowledge Transfer Partnership with Northumbria University to develop a cost-effective tuberculosis (TB) testing kit.
MedStar Washington Hospital Center geriatricians found that when medical care for frail elders with advanced illness shifts to the home, total Medicare costs were reduced by 17 percent during a two-year period.
Big changes are coming to the US health care system—some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign, and Affordable Care Act policies are all attempting to curtail overtesting—with CT scans, MRIs and any other screening often ordered unnecessarily—that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.
This week 23andMe (a genetic testing company) and Genentech (medical research company of the Roche Group) agreed a collaboration to undertake whole genome sequencing for 3,000 patients with Parkinson's disease. The genetic information will be collected by 23andMe and used by Genentech to identify new therapeutic targets for treating Parkinson's disease.
› Verified 4 days ago
Entity Name | Robert B Strimling Md & Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326018136 PECOS PAC ID: 6901934561 Enrollment ID: O20100503000604 |
News Archive
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Leading micro-engineering company Epigem today announced a new Knowledge Transfer Partnership with Northumbria University to develop a cost-effective tuberculosis (TB) testing kit.
MedStar Washington Hospital Center geriatricians found that when medical care for frail elders with advanced illness shifts to the home, total Medicare costs were reduced by 17 percent during a two-year period.
Big changes are coming to the US health care system—some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign, and Affordable Care Act policies are all attempting to curtail overtesting—with CT scans, MRIs and any other screening often ordered unnecessarily—that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.
This week 23andMe (a genetic testing company) and Genentech (medical research company of the Roche Group) agreed a collaboration to undertake whole genome sequencing for 3,000 patients with Parkinson's disease. The genetic information will be collected by 23andMe and used by Genentech to identify new therapeutic targets for treating Parkinson's disease.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lionel Julian Handler, MD 10105 Banburry Cross Dr, Suite 350, Las Vegas, NV 89144 Ph: (702) 243-6400 | Dr Lionel Julian Handler, MD 10105 Banburry Cross Dr, Suite 350, Las Vegas, NV 89144 Ph: (702) 243-6400 |
News Archive
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Leading micro-engineering company Epigem today announced a new Knowledge Transfer Partnership with Northumbria University to develop a cost-effective tuberculosis (TB) testing kit.
MedStar Washington Hospital Center geriatricians found that when medical care for frail elders with advanced illness shifts to the home, total Medicare costs were reduced by 17 percent during a two-year period.
Big changes are coming to the US health care system—some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign, and Affordable Care Act policies are all attempting to curtail overtesting—with CT scans, MRIs and any other screening often ordered unnecessarily—that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.
This week 23andMe (a genetic testing company) and Genentech (medical research company of the Roche Group) agreed a collaboration to undertake whole genome sequencing for 3,000 patients with Parkinson's disease. The genetic information will be collected by 23andMe and used by Genentech to identify new therapeutic targets for treating Parkinson's disease.
› Verified 4 days ago
Mrs. Miriam S Bettencourt, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6170 N Durango Dr Ste 140, Las Vegas, NV 89149 Phone: 702-430-5333 | |
Dr. Alison Yah-san Tam, D.O. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8530 W. Sunset Rd #130, Las Vegas, NV 89113 Phone: 702-822-2100 Fax: 702-822-2105 | |
Dr. Dominick J Addonizio I, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 653 N Town Center Dr, Las Vegas, NV 89144 Phone: 702-450-7546 Fax: 702-869-6146 | |
Dr. James Del Rosso, DO Dermatology Medicare: Medicare Enrolled Practice Location: 9097 W Post Rd Ste 100, Las Vegas, NV 89148 Phone: 702-430-5333 Fax: 702-430-5335 | |
Elizabeth Ann Langford, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6460 Medical Center St Ste 350, Las Vegas, NV 89148 Phone: 702-255-6647 Fax: 702-933-1444 | |
Dr. Jaldeep H Daulat, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3975 S Durango Dr Ste 107, Las Vegas, NV 89147 Phone: 702-628-5333 Fax: 702-974-0440 |